OraSure Technologies | OSUR - Interest Expense On Debt


OraSure Technologies reported 1.67M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 29M 4M Jun/2026
AngioDynamics USD 102K 2K Sep/2025
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 28.52M 1.82M Sep/2026
Danaher USD 135M 28M Sep/2026
Dentsply International USD 27M 5M Sep/2026
Dexcom USD 3.1M 100K Sep/2026
Illumina USD 24M 0 Sep/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 203M 6M Sep/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 15.68M 1.57M Sep/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.78B 66M Sep/2026
Repligen USD 5.71M 49K Sep/2026
Revvity USD 20.81M 2.18M Sep/2026
STAAR Surgical USD 900K 100K Jun/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Trinity Biotech USD 3.33M 50K Sep/2025
Waters USD 53M 2M Sep/2026